STACK_RATINGSby NERD_PROTOCOLS
< LEADERBOARD/s/folateVitamins

Folate / Folic Acid

Also sold as: Vitamin B9 · Folic acid · L-methylfolate · 5-MTHF

Folate supports one-carbon metabolism and DNA synthesis. Folic acid has established periconceptional evidence for preventing neural tube defects; that indication does not establish general cardiovascular or cognitive enhancement.

Focus Longevity

COMMUNITY_STACK_RATINGlive · n=0

Community

Not enough ratings yet: 0 of 10

Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.

+ Rate your experience (30 sec, anonymous)

NERD_PROTOCOL // EVIDENCE_MATRIXper goal

Research

FocusLimited · no benefitLongevityModerate · no benefit
  • Focus: Trials and reviews in cognitively healthy middle-aged and older adults generally find no meaningful cognitive benefit; high-homocysteine subgroups remain uncertain.
  • Longevity: Lower homocysteine has not consistently translated into fewer myocardial infarctions or lower overall or cardiovascular mortality.

REALITY CHECK // MTHFR variants do not make all folic acid useless. Folic acid has the strongest hard-endpoint pregnancy record, whereas short-term methylfolate bioavailability does not establish superior prevention of birth defects. UMFA concerns and cancer hypotheses require context, not blanket claims of harm.

Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.

Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.

CHECK_YOUR_BOTTLE.EXEruns in your browser · nothing is sent or stored

Check your bottle

Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.

Try a common label:
The label number is the…

Enter the amount from your label to see the result.

How it was studied

01 // STUDIED_DOSE_RANGE
Form and population matter
Periconceptional studies/guidance in the dossier use 400-800 micrograms/day (0.4-0.8 mg), from at least four weeks before conception through the first 12 weeks of pregnancy. Psychiatric methylfolate discussions involve 7.5-15 mg, a separate medical use rather than a routine nutrient target.
02 // TIMING_&_MATRIX
Administration context
Regular intake across the periconceptional window matters more than time of day. Do not substitute leucovorin rescue or psychiatric methylfolate regimens for nutritional intake.
03 // EVALUATION_WINDOW
Match the studied window
Neural tube prevention depends on intake before conception and early gestation. Homocysteine and chronic disease trials are not acute focus tests.
04 // SAFETY_&_QUALITY_GATE
Review limits and medicines
The dossier cites a 1 mg/day adult limit for synthetic folic acid from supplements and fortified food, excluding natural food folate. Current jurisdiction and form-specific applicability need primary-document review; numeric calculator ULs remain unset to avoid extending the folic-acid limit to every folate salt. Assess untreated B12 deficiency before high-dose folate: blood counts can improve while B12-related neurological injury continues. Pregnancy is an indication for appropriate folate, not a contraindication. Prior neural tube defects, anticonvulsants, psychiatric dosing and existing neoplastic lesions require individualized care.

UPPER LIMIT // The dossier cites a 1 mg/day adult limit for synthetic folic acid from supplements and fortified food, excluding natural food folate. Current jurisdiction and form-specific applicability need primary-document review; numeric calculator ULs remain unset to avoid extending the folic-acid limit to every folate salt.

NERD'S NOTENerd Protocols · a clinical and sports dietitian based in the EU

Summary

The clearest clinical benefit is prevention of fetal neural tube defects around conception. Homocysteine falls reliably, but it is a surrogate, and mortality and coronary outcomes do not follow it. Methylfolate augmentation of depression treatment is a clinician-led, mixed-evidence indication.

Mechanism

Reduced folates carry one-carbon units for nucleotide synthesis and methylation. Folic acid requires reduction and conversion; 5-MTHF bypasses DHFR/MTHFR steps, while B12 status remains important for safe interpretation of anemia and neurological symptoms.

Typical studied dose

Periconceptional studies/guidance in the dossier use 400-800 micrograms/day (0.4-0.8 mg), from at least four weeks before conception through the first 12 weeks of pregnancy. Psychiatric methylfolate discussions involve 7.5-15 mg, a separate medical use rather than a routine nutrient target.

Upper limit

The dossier cites a 1 mg/day adult limit for synthetic folic acid from supplements and fortified food, excluding natural food folate. Current jurisdiction and form-specific applicability need primary-document review; numeric calculator ULs remain unset to avoid extending the folic-acid limit to every folate salt.

POPULAR_STACKScombos with n ≥ 5

Popular stacks with Folate / Folic Acid

Not enough stack data yet. A combination with Folate / Folic Acid appears here once 5 people rate the same set.

> Rate my stack

Forms and label traps

Forms compared
Form on labelActive contentStudied range / dayAbsorption & GI toleranceVerdict
Folic acid, declared nutrient mass
Best for: Periconceptional evidence base.
 Extract weight · ~100% marker 0.4–0.8 mg Stable synthetic form; requires metabolic conversion.
Usually well tolerated.		 Studied standard [FORM // REFERENCE]
Enter mg of folic acid, not micrograms or dietary folate equivalents; 400 micrograms = 0.4 mg. No absorption multiplier is applied.
L-5-MTHF / L-methylfolate, declared nutrient mass
Best for: Alternative folate form when clinically appropriate.
 Unstandardized: active content unknown no comparable trial range Short-term bioavailability was equivalent to folic acid in men in the cited trial.
Usually tolerated; agitation reports at high doses are not a defined syndrome.		 Good option [FORM // CHECK_BASIS]
No salt-to-nutrient conversion or routine dose equivalence is established here. Psychiatric milligram regimens are separate from nutritional microgram use.
Folinic acid / leucovorin
Best for: Specific clinician-directed folate therapy.
 Unstandardized: active content unknown no comparable trial range Reduced folate with intracellular conversion.
Generally tolerated; context is medical.		 Good option [FORM // CHECK_BASIS]
Not interchangeable with folic acid or 5-MTHF on the basis of the bottle mass. Unknown comparable clinical interval is deliberately unavailable.

Common label traps

  • TRAP_01 // MTHFR means folic acid never works
    A common variant does not establish inability to use all folic acid, nor superiority of methylfolate for neural tube defect prevention.
  • TRAP_02 // Lower homocysteine means a longer life
    The biochemical reduction is reliable, but trials do not consistently show fewer coronary events or deaths.
  • TRAP_03 // Folic acid simply causes cancer
    Dietary associations and supplementation RCTs differ. The dossier reports no overall CRC increase in the cited trial meta-analysis; lesion timing and chronic megadoses remain cautions.

Other outcomes studied

Outside the five leaderboard goals. Same evidence levels as above.

  • NEURAL TUBE DEFECT PREVENTION Strong · benefit
    Periconceptional folate review: relative risk about 0.31, roughly 69% relative reduction. This pregnancy endpoint must not be mapped to anxiety.
    PMID 26662928 PMID 37526714
  • HOMOCYSTEINE Strong · benefit
    Randomized-trial meta-analysis reports roughly 25% reduction, influenced by baseline status. This is a surrogate, not proof of cardiac protection.
    PMID 11339443 PMID 25323814
  • STROKE Limited · benefit
    Meta-analysis reports RR 0.82, with stronger signals in unfortified populations and longer trials; this does not establish improved everyday focus.
    PMID 17544768 PMID 29078842
  • DEPRESSION AUGMENTATION Limited · benefit
    Evidence is mixed: FolATED was negative, while reviews suggest a modest, uncertain signal for methylfolate in selected patients. This is psychiatric treatment augmentation.
    PMID 25052890 PMID 29442609
  • COLORECTAL CANCER Limited · no benefit
    Dietary folate associations are observational. Supplementation trials do not establish CRC prevention or an overall increase in the cited meta-analysis; high-dose lesion-progression hypotheses remain uncertain.
    PMID 19863600 PMID 41314820
  • PREECLAMPSIA Moderate · no benefit
    High-dose supplementation did not prevent preeclampsia in the dossier evidence; this does not negate periconceptional neural tube prevention.
    PMID 29882975
  • MIGRAINE Limited · benefit
    Small, low-quality B6/folate/B12 studies suggest benefit in selected groups, often with MTHFR variants; the effect cannot be isolated to folate.
    PMID 32279306
  • FOLATE-DEFICIENCY ANEMIA Moderate · benefit
    Correction of confirmed folate-deficiency megaloblastic anemia is established clinical practice; no dedicated numerical trial citation is supplied. Exclude concurrent B12 deficiency.

Reader questions

Which form should I choose if I have an MTHFR variant?

A variant alone does not justify replacing every folic-acid product or using high-dose methylfolate. Folic acid has pregnancy hard-endpoint evidence, and short-term absorption comparisons do not establish universal clinical superiority.

Why do some methylfolate products contain 15 mg?

That is a psychiatric augmentation scale, not a routine nutritional dose. Discuss symptoms, antidepressants and B12 status with the treating clinician rather than escalating from a microgram prenatal dose.

Is folic acid appropriate in pregnancy?

The dossier supports 400-800 micrograms/day around conception. Previous neural tube defects and certain medicines change care needs; arrange individualized prenatal advice.

What if methylfolate makes me anxious or irritable?

Do not assume a proven overmethylation diagnosis. Stop escalating and review dose, medicines and symptoms with a clinician, particularly with psychiatric treatment.

Stack interactions

  • Caution Vitamin B12, metformin and proton pump inhibitors [CAUTION // REVIEW_CONTEXT]
    Folate can mask the hematological presentation of B12 deficiency. Metformin and long-term acid suppression can worsen B12 status; evaluate B12 rather than relying on a normal blood count.
    PMID 38987872
  • Caution Methotrexate and folate antagonists [CAUTION // REVIEW_CONTEXT]
    Folic acid may reduce rheumatology methotrexate toxicity, whereas folinic-acid rescue in oncology is a separate regimen. Trimethoprim, sulfonamides and sulfasalazine alter folate handling. The dossier lacks dedicated interaction trials; prescribing teams determine use.
  • Caution Antidepressants and anticonvulsants [CAUTION // REVIEW_CONTEXT]
    Methylfolate augmentation has mixed clinical evidence and belongs with the treating clinician. Phenytoin and other anticonvulsants require review because interactions can be bidirectional.
    PMID 24524097
  • Caution Riboflavin and B6 [CAUTION // REVIEW_CONTEXT]
    These are pathway cofactors. Their biochemical role does not prove additional clinical benefit from high-dose stacking without deficiency.

Red flags: interactions and who should avoid it

Interactions

Vitamin B12, metformin and proton pump inhibitors: Folate can mask the hematological presentation of B12 deficiency. Metformin and long-term acid suppression can worsen B12 status; evaluate B12 rather than relying on a normal blood count. Methotrexate and folate antagonists: Folic acid may reduce rheumatology methotrexate toxicity, whereas folinic-acid rescue in oncology is a separate regimen. Trimethoprim, sulfonamides and sulfasalazine alter folate handling. The dossier lacks dedicated interaction trials; prescribing teams determine use. Antidepressants and anticonvulsants: Methylfolate augmentation has mixed clinical evidence and belongs with the treating clinician. Phenytoin and other anticonvulsants require review because interactions can be bidirectional. Riboflavin and B6: These are pathway cofactors. Their biochemical role does not prove additional clinical benefit from high-dose stacking without deficiency.

Avoid or ask a doctor first if

Assess untreated B12 deficiency before high-dose folate: blood counts can improve while B12-related neurological injury continues. Pregnancy is an indication for appropriate folate, not a contraindication. Prior neural tube defects, anticonvulsants, psychiatric dosing and existing neoplastic lesions require individualized care.

Sources (PubMed, 19)

  1. Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
    PMID 26662928 · 2015 · systematic review / meta-analysis
    Periconceptional folate and neural tube defect prevention.
  2. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    PMID 37526714 · 2023 · systematic review / meta-analysis
    Updated evidence for prevention of neural tube defects.
  3. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
    PMID 11339443 · 2000 · systematic review / meta-analysis
    Homocysteine lowering in randomized trials.
  4. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.
    PMID 17544768 · 2007 · systematic review / meta-analysis
    Stroke signal depends on trial and population context.
  5. Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials.
    PMID 27528407 · 2016 · systematic review / meta-analysis
    Cardiovascular endpoints do not uniformly follow homocysteine lowering.
  6. Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation.
    PMID 25052890 · 2014 · randomized controlled trial
    Negative FolATED depression augmentation trial.
  7. Caveat emptor: Folate in unipolar depressive illness, a systematic review and meta-analysis.
    PMID 29442609 · 2018 · systematic review / meta-analysis
    Mixed folate augmentation evidence.
  8. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.
    PMID 30556597 · 2018 · systematic review / meta-analysis
    No established cognition-maintenance benefit in healthy adults.
  9. Folic acid supplementation and colorectal cancer risk: a meta-analysis.
    PMID 19863600 · 2011 · systematic review / meta-analysis
    Trial evidence on colorectal cancer risk.
  10. Folate exposures and risk of colorectal cancer: an umbrella review of meta-analyses of observational studies and randomised controlled trials.
    PMID 41314820 · 2025 · systematic review / meta-analysis
    Distinguishes observational and randomized folate/CRC evidence.
  11. Maternal folic acid supplementation for the prevention of preeclampsia: A systematic review and meta-analysis.
    PMID 29882975 · 2018 · systematic review / meta-analysis
    No established preeclampsia prevention from high-dose folate.
  12. Pyridoxine, folate and cobalamin for migraine: A systematic review.
    PMID 32279306 · 2020 · systematic review / meta-analysis
    Limited combination-vitamin migraine evidence.
  13. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men.
    PMID 14988450 · 2004 · randomized controlled trial
    Short-term folate form bioavailability comparison in men.
  14. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.
    PMID 20608755 · 2010 · narrative review
    Clinical folate pharmacokinetic differences.
  15. Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?
    PMID 38987872 · 2024 · narrative review
    B12 deficiency and excess folic acid clinical cautions.
  16. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies.
    PMID 26862004 · 2016 · narrative review
    Review of nervous-system concerns behind folic-acid limits.
  17. The effects of folinic acid and l-methylfolate supplementation on serum total homocysteine levels in healthy adults.
    PMID 38056998 · 2023 · randomized controlled trial
    Folinic acid and methylfolate comparison for homocysteine.
  18. Pharmacokinetics of (6S)-5-Methyltetrahydrofolate dicholine salt compared to folic acid: a randomized double-blind single dose cross-over study.
    PMID 41059007 · 2025 · randomized controlled trial
    Single-dose methylfolate salt pharmacokinetics.
  19. Folate augmentation of antidepressant response.
    PMID 24524097 · 2013 · narrative review
    Clinical antidepressant augmentation context.

Community comments

No approved comments yet. Comments are held for moderation.

+ Rate this